Clinical trialNCT01247571CompletedPhase 2Interventional

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

SponsorNational Cancer Institute (NCI)Enrollment22Recurrent Uterine Corpus SarcomaUterine Carcinosarcoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase II trial studies how well pazopanib hydrochloride works in treating patients with uterine cancer that has come back or has not responded to treatment. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Pazopanib hydrochloride may also stop the growth of uterine cancer by blocking blood flow to the tumor.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Susana Campos
NRG Oncology
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
the Hospital of Central Connecticut
New Britain, Connecticut, United States
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
Florida Hospital Orlando
Orlando, Florida, United States
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Saint Vincent Oncology Center
Indianapolis, Indiana, United States
Medstar Franklin Square Medical Center/weinberg Cancer Institute
Baltimore, Maryland, United States
Michigan Cancer Research Consortium Ccop
Ann Arbor, Michigan, United States
Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
Saint John Hospital and Medical Center
Detroit, Michigan, United States
Genesys Regional Medical Center-West Flint Campus
Flint, Michigan, United States
Hurley Medical Center
Flint, Michigan, United States
Genesys Regional Medical Center
Grand Blanc, Michigan, United States
Allegiance Health
Jackson, Michigan, United States
Sparrow Hospital
Lansing, Michigan, United States
Saint Mary Mercy Hospital
Livonia, Michigan, United States
Saint Joseph Mercy Oakland
Pontiac, Michigan, United States
Saint Joseph Mercy Port Huron
Port Huron, Michigan, United States
Saint Mary'S of Michigan
Saginaw, Michigan, United States
Saint John Macomb-Oakland Hospital
Warren, Michigan, United States
Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
Coxhealth South Hospital
Springfield, Missouri, United States
Nebraska Methodist Hospital
Omaha, Nebraska, United States
Cooper Hospital University Medical Center
Camden, New Jersey, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
Novant Health Presbyterian Medical Center
Charlotte, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Case Western Reserve University
Cleveland, Ohio, United States
Metrohealth Medical Center
Cleveland, Ohio, United States
Riverside Methodist Hospital
Columbus, Ohio, United States
Lake University Ireland Cancer Center
Mentor, Ohio, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
Abington Memorial Hospital
Abington, Pennsylvania, United States

1 more site on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Pazopanib →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2011
Primary completion: 31 Jan 2016
Completion: 31 Jan 2016
Last update posted: 8 Aug 2019
Registered enrollment: 22
Registry id: NCT01247571

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.